ERCC6L and lung adenocarcinoma: Remarkably, PICH knockout mice exhibited a significantly extended lifespan compared to PICH wild‐type mice (Figure 4H), highlighting the potential therapeutic value of targeting PICH for the treatment of lung adenocarcinoma.